Retinal neurotoxicity of nitric oxide donors with different half-life of nitric oxide release: Involvement of N-methyl-D-aspartate receptor

Journal of Pharmacological Sciences

Volumn 92, Issue 4, 2003, Pages 428-432

  Takahata, Kazue ^b   Katsuki, Hiroshi ^a   Kume, Toshiaki ^a   Ito, Ken ^a   Tochikawa, Yoshinaga ^b   Muraoka, Shizuko ^b   Yoneda, Fumio ^b   Kashii, Satoshi ^a   Honda, Yoshihito ^a   Akaike, Akinori ^a  

^a KYOTO UNIVERSITY   (Japan)

^b Fujimoto Pharmaceutical Corporation   (Japan)

Author keywords

Neurodegeneration; Nitric oxide; Retina

Indexed keywords

2 (4 CARBOXYPHENYL) 4,4,5,5 TETRAMETHYLIMIDAZOLINE 1 OXYL 3 OXIDE; 3 (3 AMINOPROPYL) 1 HYDROXY 3 ISOPROPYL 2 OXO 1 TRIAZENE; 3,3 BIS(2 AMINOETHYL) 1 HYDROXY 2 OXOTRIAZENE; DIZOCILPINE; GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NITRIC OXIDE; NITRIC OXIDE DONOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DENSITY; CONTROLLED STUDY; GANGLION; HALF LIFE TIME; MALE; NERVE CELL DEGENERATION; NEUROTOXICITY; NONHUMAN; RAT; RETINA INJURY; RETINA INNER PLEXIFORM LAYER;

EID: 10744224458     PISSN: 13478613     EISSN: None     Source Type: Journal    
DOI: 10.1254/jphs.92.428     Document Type: Article

References (14)

1. Ambati J, Chalam KV, Chawla DK, et al. Elevated γ-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Arch Ophthalmol. 1997;115:1161-1166.
2. Yoles E, Schwartz M. Elevation of intraocular glutamate levels in rats with partial lesion of the optic nerve. Arch Ophthalmol. 1998;116:906-910.
3. ω-Nitro-L-arginine methyl ester protects retinal neurons against N-methyl-D-aspartate-induced neurotoxicity in vivo. Eur J Pharmacol. 1997;328:45-49.
4. Adachi K, Kashii S, Masai H, et al. Mechanism of the pathogenesis of glutamate neurotoxicity in retinal ischemia. Graefes Arch Clin Exp Ophthalmol. 1998;236:766-774.
5. Neufeld AH, Shareef S, Pena J. Cellular localization of neuronal nitric oxide synthase (NOS-1) in the human and rat retina. J Comp Neurol. 2000;416:269-275.
6. Kobayashi M, Kuroiwa T, Shimokawa R, Okeda R, Tokoro T. Nitric oxide synthase expression in ischemic rat retinas. Jpn J Ophthalmol. 2000;44:235-244.
7. Hrabie JA, Klose JR, Wink DA, Keefer LK. New nitric oxide-releasing zwitterions derived from polyamines. J Org Chem. 1993;58:1472-1476.
8. Takahata K, Katsuki H, Kume T, et al. Retinal neuronal death induced by intraocular administration of a nitric oxide donor and its rescue by neurotrophic factors in rats. Invest Ophthalmol Vis Sci. 2003;44:1760-1766.
9. Oku H, Yamaguchi H, Sugiyama T, Kojima S, Ota M, Azuma I. Retinal toxicity of nitric oxide released by administration of a nitric oxide donor in the albino rabbit. Invest Ophthalmol Vis Sci. 1997;38:2540-2544.
10. Behar-Cohen FF, Goureau O, D'Hermies F, Courtois Y. Decreased intraocular pressure induced by nitric oxide donors is correlated to nitrite production in the rabbit eye. Invest Ophthalmol Vis Sci. 1996;37:1711-1715.
11. Mizuno K, Koide T, Yoshimura M, Araie M. Neuroprotective effect and intraocular penetration of nipradilol, a β-blocker with nitric oxide donative action. Invest Ophthalmol Vis Sci. 2001;42:688-694.
12. Bal-Price A, Brown GC. Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and exicitotoxicity. J Neurosci. 2001;21:6480-6491.
13. Stewart VC, Heslegrave AJ, Brown GC, Cark JB, Heales SJR. Nitric oxide-dependent damage to neuronal mitochondria involves the NMDA receptor. Eur J Neurosci. 2002;15:458-464.
14. Trabace L, Kendrick KM. Nitric oxide can differentially modulate striatal neurotransmitter concentrations via soluble guanylate cyclase and peroxynitrite formation. J Neurochem. 2000;75:1664-1674.